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Dendrimer-enhanced MRI as a diagnostic and prognostic
biomarker of sepsis-induced acute renal failure in aged mice.
Background. Acute renal failure (ARF) induced by sepsis
has a high mortality. In an aged mouse model of sepsis-induced
ARF we have previously shown that renal injury occurs before
serum creatinine is elevated. Development of a noninvasive
biomarker that could diagnose renal dysfunction early in sepsis
and monitor the response to therapy would be very valuable.
Methods. We performed magnetic resonance imaging (MRI)
with gadolinium-based G4 dendrimer intravenous contrast in a
fluid- and antibiotic-treated cecal ligation and puncture (CLP)
sepsis model in aged mice. Imaging was also performed in a
mouse volume depletion model and in models of ARF induced
by ischemia/reperfusion (I/R) and cisplatin.
Results. Twenty hours post-CLP, aged mice had a distinct
pattern of renal injury using dendrimer-enhanced MRI. This
pattern was different from renal injury induced by either cis-
platin or I/R. Prerenal azotemia induced by volume depletion
was distinguished from sepsis by dendrimer-enhanced MRI.
Dendrimer-enhanced MRI detected renal dysfunction 6 hours
post-CLP, a time when serum creatinine was still normal. Ethyl
pyruvate reversed the renal dysfunction detected by dendrimer-
enhanced MRI at 20 hours, but not at 6 hours post-CLP. The
appearance of renal dysfunction on dendrimer-enhanced MRI
at 6 hours post-CLP predicted the length of survival.
Conclusion. Dendrimer-enhanced MRI is a novel biomarker
that provides information for the early diagnosis, drug respon-
siveness, and prognosis of sepsis-induced ARF.
Acute renal failure (ARF) is a relatively common
life-threatening illness occurring in 5% to 20% of in-
tensive care unit patients [1–3]. Sepsis is a major cause
and sepsis-induced ARF has a particularly poor out-
come with a mortality of 50% to 80% [4–6]. This is
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in stark contrast to ARF from other causes, for exam-
ple, ARF induced by nephrotoxic radiocontrast has a
reported mortality as low as 2% [7]. Therefore, treat-
ments to prevent or treat sepsis-induced ARF are highly
sought after to alleviate this condition. If therapies are
to be effectively tested in human studies then renal im-
pairment needs to be diagnosed early in a septic pa-
tient and the cause be differentiated from other insults
such as ischemia and nephrotoxins. Development of a
noninvasive biomarker which could detect renal injury
early, locate the site of injury, and determine the cause
would be extremely valuable. For drug development it
would be very useful if the biomarker could track suc-
cessful drug treatment and serve as an intermediate end
point. This paper describes the results using one such
biomarker: a novel magnetic resonance imaging (MRI)
technique.
The renal ischemia/reperfusion (I/R) model is often
used as a rodent model of ARF [8]. However, the pat-
tern of renal injury after sepsis is different from that fol-
lowing I/R [9]. A mouse model of sepsis-induced ARF
has recently been developed based on the cecal ligation
and puncture (CLP) technique to generate polymicro-
bial sepsis [10]. This model is distinct from typical mouse
CLP models in that fluid and antibiotic resuscitation is
administered to aged mice. The mice develop multiorgan
failure, including ARF, which resembles human sepsis.
Histologic changes consist of vacuolization throughout
the kidney and no inflammation, quite distinct from is-
chemic or nephrotoxic models. The lack of striking renal
histological changes is similar to the findings at human
autopsy of septic patients [11]. The protein biomarker
CYR61 is increased in both ischemic- and sepsis-induced
ARF and, therefore, cannot distinguish the cause [10, 12].
However, using histology and kidney tissue CYR61, it ap-
pears that renal injury occurs early in sepsis; up to 6 hours
before serum creatinine is raised. This suggests that in
sepsis there is an early “silent” period of ARF before the
serum creatinine becomes elevated.
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We have previously demonstrated that dynamic
high-resolution micro-MRI combined with a novel
dendrimer-based macromolecular renal MRI contrast
agent (“dendrimer-enhanced MRI”) can be a powerful
tool for in vivo observation of renal structure, function,
and injury [13, 14]. In this paper we investigate whether
this technique can be used as a biomarker for sepsis-
induced ARF.
METHODS
Animals
Animal care followed National Institutes of Health
(NIH) criteria for the care and use of laboratory animals
in research. Young (7 to 8 weeks) female BALB/c nu/nu
mice and aged (42 to 44 weeks) male C57BL/6 mice (NIH,
Frederick, MD, USA) had free access to water and chow
(NIH-07 Rodent Chow), except during volume depletion
studies (Zeigler Bros., Gardners, PA, USA), before and
after surgery. Aged mice were housed individually.
CLP-induced ARF
Aged C57BL/6 mice were anesthetized using isoflu-
rane inhalation. After laparotomy, a 5–0 silk ligature was
placed 1 cm from the cecal tip. The cecum was punc-
tured twice with a 21-gauge needle and gently squeezed
to express a 1 mm column of fecal material. In sham-
operated animals, the cecum was located, but neither lig-
ated nor punctured. The abdominal incision was closed
in two layers with 6–0 nylon sutures. After surgery, 1 mL
of prewarmed normal saline was given intraperitoneally
and 1.5 mL given subcutaneously. All animals received a
broad-spectrum antibiotic (imipenem/cilastatin 14 mg/kg
subcutaneously) at 6 hours, and 1.5 mL of 3/4 normal
saline was administered at 6 and 18 hours after surgery
by subcutaneous injection. At the time of sacrifice, blood
was collected by cardiac puncture for measurement of
serum creatinine by high-performance liquid chromatog-
raphy (HPLC) [15] and the kidneys were harvested for
histologic evaluation. The 10% formalin-fixed, paraffin-
embedded kidney sections were stained with periodic
acid-Schiff (PAS) reagent.
For survival studies the size of the needle used for ce-
cal puncture was varied between 21 and 28 g. The animals
were monitored twice daily and received 1.5 mL 3/4 nor-
mal saline and antibiotic twice daily. Those mice surviving
to day 7 were imaged again by dendrimer-enhanced MRI.
Effect of ethyl pyruvate on CLP-induced ARF
Aged C57BL/6 mice received 0.4 mL of Ringer’s lactate
(130 mmol/L Na+, 4 mmol/L K+, 2.7 mmol/L Ca2+, 109
mmol/L Cl−, and 28 mmol/L lactate) or a similar volume
of freshly made Ringer’s ethyl pyruvate where isomo-
lar ethyl pyruvate (Sigma Chemical Co., St. Louis, MO,
USA) was substituted for sodium lactate. Doses were in-
jected intraperitoneally at 0 and 6 after CLP surgery.
Volume depletion
Aged C57BL/6 mice were weighed then received two
subcutaneous injections of furosemide (40 mg/kg) 3 hours
apart. Control mice received two injections of sterile wa-
ter vehicle. Furosemide-treated mice then were given free
access to low sodium diet (Teklad, Madison, WI, USA)
(Diet no. 7034) (sodium 0.1%). Control mice had free
access to NIH-07 Rodent Chow (Zeigler Bros.) (sodium
0.31%). Twenty-four hours after the first injection, the
mice were reweighed, then MRI was performed. After
imaging, urine was collected directly from the bladder
and blood was collected by cardiac puncture.
Cisplatin-induced nephrotoxicity
Seven-week-old female BALB/c nu/nu mice were in-
jected intraperitoneally with 400 lg of cisplatin (Sigma
Chemical Co.) in 400 lL of saline without anesthesia.
The mice were studied by micro-MRI 3 days after the
cisplatin injection.
I/R-induced ARF
Seven-week-old female BALB/c nu/nu mice were anes-
thetized with an injection of 100 mg/kg ketamine, 10 mg/
kg xylazine, and 1 mg/kg acepromazine intramuscularly.
The abdomen was shaved, a midline incision was made,
and both renal pedicles were cross-clamped for 40 min-
utes. Both kidneys were inspected for ischemia after
2 minutes. To help maintain thermoregulation during
surgery, the abdomen contents were replaced and the ab-
domen was temporarily closed with several sutures. The
abdomen was reopened 40 minutes after clamping and
the clamps were removed. The kidneys were again in-
spected for restoration of blood flow, and 1 mL of pre-
warmed normal saline was instilled into the abdominal
cavity. The abdomen was closed in two layers, and MRI
images were obtained 4 hours later.
Dendrimer-enhanced MRI
The method for synthesis of contrast agent was previ-
ously described [13]. Dynamic three-dimensional micro-
MRI scans of the kidney in the mice were obtained
with injection of 0.03 mmol gadolinium (Gd)/kg of G4D-
(1B4M-Gd)64 using a 1.5 Tesla (T) superconductive mag-
net unit (Signa LX, General Electric Medical System,
Milwaukee, WI, USA). All images were obtained using
a 1 inch round surface coil (Birdcage type) fixed by an
in-house constructed coil holder. The mice were anes-
thetized with 1.15 mg of sodium pentobarbital (Dain-
abot, Tokyo, Japan) and placed at the center of the
coils. To avoid artifacts from bowel movement, 2.5 mg of
butylscopolamine was added to the anesthetized agent.
For the dynamic study, the T1-weighted magnetization
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Fig. 1. The effect of sepsis on dendrimer-
enhanced magnetic resonance imaging (MRI)
of the kidney. MRI scans 1, 9, and 17 min-
utes after intravenous injection of G4 den-
drimer. (A) Sham-operated mouse 20 hours
after surgery. (B) Cecal ligation and puncture
(CLP)-operated mouse 20 hours after surgery.
prepared three-diminsional fast-spoiled gradient-echo
technique with chemical fat-suppression was used for all
mice. The images were acquired at preinjection and 1, 3,
5, 7, 9, 11, 13, 15, and 17 minutes after injection of the
contrast agent. After 20 minutes, a full-body image was
obtained. The coronal images were reconstructed with
0.8 mm section thickness with 0.4 mm overlap. The field
of view was 8 × 4 cm and the size of matrix was 512 × 256.
The slice data were analyzed using commercial software
(Advantage Windows, General Electric Medical System).
The MRI changes were scored by three criteria: (1)
presence of stripes in outer medulla/cortex: 1, clearly
present; 2, vague; and 3, none; (2) contrast in pelvis:
1, present and 3 none; and (3) kidney tissue “bright-
ness” compared to renal vein: 1, kidney brighter than
vessels; 2, vessels same as kidney; and 3, kidney darker
than aorta/renal vessels or blood vessels visible over kid-
ney. The three subscores were added together. There-
fore, the score range is from 3 (normal) increasing to 9
with increasing injury. The MRI scans were scored by
two masked independent referees and a consensus score
determined.
Statistics
Results are expressed as mean ± SEM. Significance
was determined by unpaired t test.
RESULTS
Dendrimer-enhanced MRI in sepsis, ischemia, and
nephrotoxic models
Kidneys from sham-operated mice had alternating
light and dark stripes in the cortex and outer medulla
and the pelvis filled quickly with contrast (Fig. 1A),
as described previously for normal mouse kidneys [13].
The contrast was cleared rapidly from the blood as evi-
denced by the darker appearance of the renal vessels at 17
minutes after injection of contrast agent (Fig. 1A). The
appearance of the kidney 20 hours post-CLP was very
different (Fig. 1B). The kidney was homogeneous with-
out the striped appearance. Contrast was not seen in the
pelvis and the vasculature remained “bright,” indicating
that the contrast agent was not cleared from the blood
(Fig. 1B).
Compared to controls, the mice that received
furosemide and low sodium diet developed volume de-
pletion and prerenal azotemia as evidence by weight loss
(8.0 ± 0.7% for treated v 0.6 ± 0.8% for control) (N =
5) (P < 0.05) and elevated blood urea nitrogen (BUN)
(38 ± 6 mg/dL for treated vs. 13 ± 1 mg/dL for control)
(N = 5) (P < 0.05). The dendrimer-enhanced MRI
scan of the kidney in all volume-depleted mice was in-
distinguishable from control but clearly different from
the image 20 hours post-CLP. Figures 2A and 6B show
a typical example of an image obtained after volume
depletion. This mouse had a BUN of 54 mg/dL, 7%
weight loss, and a renal failure index (urine sodium ∗
plasma creatinine/urine creatinine) of 0.9%. The pattern
following CLP (Fig. 2A) was also different from the pat-
tern seen after 40 minutes renal ischemia/4 hours reper-
fusion (Fig. 2C) or 3 days after cisplatin administration
(Fig. 2D). In both renal ischemia and cisplatin models
the outer medullary stripes were absent and there was a
high signal intensity in the outer cortex that represented
accumulation of contrast agent within the proximal con-
voluted tubules.
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Fig. 2. Patterns of dendrimer-enhanced magnetic resonance imaging
(MRI) in acute renal failure (ARF). MRI scans of the right kidney
17 minutes after intravenous injection of G4 dendrimer. (A) Volume-
depleted mouse. (B) Cecal ligation and puncture (CLP)-operated
mouse 20 hours postsurgery. (C) Kidney 4 hours after 40 minutes of
ischemia. (D) Kidney 3 days after 400 lg of cisplatin intraperitoneally.
Figure 3 shows dendrimer-enhanced MRI scans from
mice 20 hours after sham operation (Fig. 3A) or CLP
(Fig. 3B). Also shown, in Figure 3C to F, are PAS-stained
sections from the same kidneys as imaged in Figure 3A
and B. When compared to sham-operated animals, there
was vacuolar degeneration in the cortex and outer stripe
of the outer medulla of the kidney post-CLP. This is con-
sistent with the MRI scan demonstrating failure of con-
trast uptake in both cortex and medulla.
Surprisingly, at 6 hours post-CLP the image was al-
ready abnormal and similar to the appearance at 20 hours
(Fig. 4). The kidney shows a low level of contrast agent
uptake with no stripes or contrast agent in the pelvis when
compared to sham. The MRI scan did not change during
the 17 minutes of scanning (not shown).
Effect of ethyl pyruvate on dendrimer-enhanced MRI
We have previously demonstrated that ethyl pyru-
vate can prevent and treat sepsis-induced ARF [10].
Figure 5 shows the effect of ethyl pyruvate on the
dendrimer-enhanced MRI scans following CLP in aged
mice. As described above, 20 hours after CLP the kid-
ney had a distinct homogenous appearance. When ethyl
pyruvate was administered at 0 and 6 hours post-CLP, the
MRI appearance at 20 hours was that of a normal mouse
(i.e., outer medullary stripes with contrast in the pelvis)
(Fig. 5B). However, the dendrimer-enhanced MRI scan
at 6 hours was abnormal (Fig. 5A). There were no outer
medullary stripes or contrast in the pelvis at 6 hours, but
this appearance emerged by 20 hours.
Full body MRI scans were obtained 20 minutes after
intravenous injection of contrast agent. Sham-operated
mice and mice with prerenal azotemia cleared the con-
trast agent from the circulation into the bladder (Fig. 6A
and B). This clearance was inhibited at 6 and 20 hours
post-CLP (Fig. 6C and D). The contrast agent remained
in the blood pool resulting in high signal intensity in the
vasculature. Ethyl pyruvate treatment of the CLP oper-
ated mouse resulted in contrast agent clearance from the
circulation 20 hours after surgery (Fig. 6E).
Dendrimer-enhanced MRI compared to serum creatinine
As previously reported, 20 hours post-CLP the serum
creatinine level was increased and ethyl pyruvate inhib-
ited this elevation in creatinine (CLP 20 hours 0.44 ± 0.05
mg/dL, CLP + ethyl pyruvate 20 hours 0.12 ± 0.01 mg/dL)
(N = 8 per group) (P < 0.005) (Fig. 7A). At 6 hours post-
CLP the serum creatinine was not significantly different
from sham [sham 0.14 ± 0.01 mg/dL (N = 4), CLP 6 hours
0.17 ± 0.01 mg/dL (N = 8) (P > 0.05)]. The MRI scans
were scored using a semiquantitative scoring system (see
the Methods section). The MRI injury scores show that
at 6 and 20 hours post-CLP the MRI scans were signifi-
cantly different from sham (Fig. 7B). With ethyl pyruvate
treatment the MRI scans at 6 hours, but not at 20 hours,
were significantly different from sham (Fig. 7B).
Dendrimer-enhanced MRI and prognosis
To determine if the 6-hour MRI has prognostic value
the size of the puncture hole in the CLP procedure was
varied (Fig. 8). This produced a range of MRI injury
scores at 6 hours post-CLP. As the MRI renal injury score
increases the time to death was reduced (Fig. 8). Mice
surviving to 7 days were imaged again with dendrimer-
enhanced MRI. These images showed no renal abnor-
mality (data not shown).
DISCUSSION
These studies demonstrate that dendrimer-enhanced
MRI can distinguish sepsis-induced ARF from prerenal
azotemia and renal failure due to I/R or cisplatin. The
renal injury can be detected as early as 6 hours post-
CLP, before serum creatinine is elevated. The effect of
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Fig. 3. The dendrimer-enhanced magnetic
resonance imaging (MRI) scans and histology
20 hours after sham and cecal ligation and
puncture (CLP) surgery. (A) MRI of sham-
operated mouse. (B) MRI of CLP-operated
mouse. (C) Renal cortex from sham-operated
mouse. (D) Renal cortex from CLP-operated
mouse. (E) Outer stripe of outer medulla from
sham-operated mouse. (F) Outer stripe of
outer medulla from CLP-operated mouse [all
histology is periodic acid-Schiff (PAS) stained
×40).
therapy can also be monitored as ethyl pyruvate treat-
ment causes the MRI scan to return to a normal appear-
ance at 20 hours, but not at 6 hours, post-CLP treatment.
The detection of renal injury at 6 hours has prognostic
power as it predicts survival time after sepsis.
Dendrimer-enhanced MRI can distinguish between ARF
due to different etiologies
We found that the pattern of dendrimer-enhanced
MRI after sepsis is quite different from I/R or cisplatin.
In sepsis there is global renal dysfunction; cortical and
medullary kidney cells fail to accumulate contrast agent
whereas I/R (or cisplatin) causes a more selective outer
stripe dysfunction. The MRI pattern is consistent with
the location of histologic damage; the global reduction
in renal dendrimer uptake after sepsis is paralleled by
the cortical and medullary vacuolization observed in the
renal histologic sections taken post-CLP. The selective
outer stripe defect in I/R and cisplatin MRI images par-
allels the major site of histologic damage, the outer stripe
of the medulla [16, 17]. Thus, dendrimer-enhanced MRI
may predict the site of renal injury and sepsis-induced
ARF is quite different from renal ischemia.
Sepsis is a common cause of ARF and had been previ-
ously modeled in rodents by I/R because both have low
renal perfusion. However, evidence is now emerging that
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Fig. 4. Dendrimer-enhanced magnetic resonance imaging (MRI) 6
hours after sepsis. MRI scans of the right kidney 17 minutes after in-
travenous injection of the G4 dendrimer. (A) Sham-operated mouse
6 hours after surgery. (B) Cecal ligation and puncture (CLP) mouse 6
hours after surgery.
A B
Fig. 5. Effect of ethyl pyruvate on dendrimer-enhanced magnetic res-
onance imaging (MRI) following sepsis. MRI scans of the right kidney
17 minutes after intravenous injection of G4 dendrimer. (A) Cecal lig-
ation and puncture (CLP) mouse treated with ethyl pyruvate at time 0.
Image taken 6 hours after surgery. (B) CLP mouse treated with 14 lL
9M ethyl pyruvate at time 0 and 6 hours after surgery. Image taken 20
hours after surgery.
ARF induced by sepsis is a distinct entity from ischemic
ARF. In our CLP aged mouse model, ARF has a dif-
ferent histologic pattern of injury to I/R (vacuolization
vs. necrosis) and a dramatic lack of inflammation [10].
The MRI data presented in this paper support the con-
clusion that sepsis and ischemia are distinct entities. To
distinguish the cause of ARF without biopsy would be
clinically useful as the cause of ARF is often obscure or
multifactorial. To translate therapies which are effective
in specific animal models to clinical treatments requires
the recruitment of the correct patients into clinical tri-
als. Existing protein biomarkers such as CYR61, KIM-1
or NHE3 are unable to distinguish sepsis from ischemia
[10, 12, 18, 19]. Dendrimer-enhanced MRI may represent
a valuable tool for correctly classifying the etiology of a
patient’s ARF which might then improve the ability of
a trial to correctly identify an effective treatment. The
results presented here suggest that dendrimer-enhanced
MRI may be useful in defining the insult producing ARF,
especially when combined with clinical data and other
biomarkers.
Dendrimer-enhanced MRI can detect renal dysfunction
earlier than serum creatinine
Lack of an early disease marker for ARF has de-
layed timely recruitment of patients into clinical trials.
After only 6 hours, dendrimer-enhanced MRI can
demonstrate that sepsis produces changes in renal func-
tion. Even at this early time post-CLP the kidney is fail-
ing as evidenced by the lack of contrast agent uptake
in the cortex, medulla, pelvis, and bladder. At this time
point, serum creatinine is normal. Therefore, dendrimer-
enhanced MRI can detect renal failure before serum
creatinine is elevated. Previous studies have shown that
other, more invasive indicators of renal injury are present
6 hours post-CLP. Histologic changes are present and the
injury marker CYR61 is raised 6 hours post-CLP in aged
mice [10]. Both of these methods require kidney tissue;
dendrimer-enhanced MRI is the first noninvasive method
of detecting ARF early after CLP. The MRI scans 6 and 20
hours post-CLP were different from the renal image ob-
tained in prerenal azotemia induced by volume depletion.
To distinguish prerenal azotemia from established ARF
is important [20] and, thus, dendrimer-enhanced MRI is
promising as a potential clinical biomarker. While re-
nal hypoperfusion may contribute to the pathogenesis of
sepsis-induced ARF, the different MRI scans suggest that
ARF in our CLP model is not simply prerenal azotemia.
Dendrimer-enhanced MRI can track drug therapy
In developing new clinically useful therapies a
biomarker which can track drug response would be valu-
able as an intermediate end point and greatly aid the
determination of drug dosing. As reported previously,
ethyl pyruvate prevents ARF in the aged mouse model
of sepsis [10]. At 20 hours after induction of sepsis (by ce-
cal ligation and puncture) the MRI scans appear normal
with ethyl pyruvate treatment but abnormal with vehi-
cle. This demonstrates that dendrimer-enhanced MRI can
track effective drug treatment for sepsis-induced ARF.
Dendrimer-enhanced MRI may prove to be superior to
serum creatinine or even creatinine clearance as a tool
to measure drug response. The MRI technique has faster
kinetics than serum creatinine (6-hour MRI injury score
vs. 6-hour serum creatinine concentration) and provides
more direct information about kidney cell function (con-
trast agent uptake) and contrast agent excretion from the
circulation.
In the CLP model of polymicrobial sepsis administra-
tion of agents such as ethyl pyruvate or antagonists of
the cytokine HMGB1 can inhibit ARF even if started 6
Dear et al: Dendrimer-MRI in sepsis-induced ARF 2165
A B C D E
Fig. 6. Full-body dendrimer-enhanced magnetic resonance imaging (MRI) following sepsis. (A) Twenty hours after sham surgery. (B) Volume
depletion. (C) Six hours after cecal ligation and puncture (CLP). (D) Twenty hours after CLP. (E) Twenty hours after CLP + ethyl pyruvate.
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Fig. 7. The effect of ethyl pyruvate on serum creatinine and magnetic
resonance imaging (MRI) after sepsis. (A) Serum creatinine values for
sham- and cecal ligation and puncture (CLP)-treated mice. The CLP-
treated mice had blood taken at 6 or 20 hours. CLP mice were also
treated with ethyl pyruvate at time 0 and 6 hours postsurgery and blood
taken at 20 hours. Data represent four to eight mice per group. ∗P =
0.029 vs. sham; + P = 0.005 vs. CLP 20 hours. (B) MRI injury scores for
sham- and CLP-treated mice. The CLP-treated mice had images taken
at 6 or 20 hours. CLP mice were also treated with ethyl pyruvate at time
0 and 6 hours postsurgery and images taken and 6 and 20 hours. Data
represent four to eight mice per group. ∗P < 0.02 vs. sham; +P < 0.01
vs. CLP 20 hours. The creatinine and MRI data in (A) and (B) are from
the same mice in each group.
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Fig. 8. The relation between kidney magnetic resonance imaging
(MRI) injury score at 6 hours post-cecal ligation and puncture (CLP)
and survival time. Aged mice underwent CLP using a range of nee-
dle sizes for cecal puncture. The renal injury at 6 hours was defined
by dendrimer-enhanced MRI. The mice received antibiotics and fluids
twice daily and their survival monitored. Line shows linear regression
(r2 = 0.88).
to 24 hours after surgery [10, 21]. This implies that the
MRI appearance at 6 hours is reversible. The pathophys-
iology underlying this is still unclear. The MRI pattern
at 6 hours and 24 hours may represent the same process
which is reversible at the earlier time point. Alternatively,
multiple pathophysiologic mechanisms may develop over
time, for example, different contributions from changes
in renal blood flow, vascular and tubular processes occur-
ring at different time-points. It is interesting that MRI of
an early timepoint (6 hours post-CLP) fails to distinguish
ethyl pyruvate-treated from vehicle-treated septic mice.
This may suggest that the “drug target” for ethyl pyru-
vate becomes active between 6 to 24 hours post-CLP.
Recently Yang et al [21] reported that serum HMGB1
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rises 18 hours after CLP in mice and the inactive DNA
binding domain of HMGB1, the A box, protects against
ARF even when started 24 hours after CLP [21]. Ethyl
pyruvate reduces the serum level of HMGB1 [22] and,
therefore, it is possible that reduction of the levels of this
cytokine may represent, in part, the mechanism of action
of ethyl pyruvate.
Early MRI provides information about severity of illness
and survival
By varying the needle size used for cecal puncture a
range of renal injury at 6 hours post-CLP was produced.
The resulting MRI scans varied from normal to complete
absence of kidney stripes and contrast agent in the pelvis.
The severity of the MRI scan at 6 hours correlated with
the length of survival despite continued fluid and antibi-
otic treatment. Therefore, dendrimer-enhanced MRI can
provide prognostic survival information. It is likely that
survival after CLP in the mouse model depends on the
function of multiple organs and the prognostic value of
imaging the kidney may reflect the severity of multiorgan
dysfunction. Indeed, at 6 hours post-CLP splenic injury
could also be detected (data not shown). Human studies
in the critical care setting have established that acute re-
nal failure is a risk factor for death [5, 23, 24]. Therefore,
dendrimer-enhanced MRI may be a prognostic marker
by virtue of its ability to quantify renal contribution to
the excess mortality in sepsis.
While this is data collected in the laboratory setting,
imaging a septic patient early would be very valuable if
outcome in the clinical setting could be predicted. While
unlikely such an MRI technique would be used in routine
clinical practice, very specific roles in clinical research
projects and early phase clinical trials can be envisioned.
One of the many remaining challenges is to develop a
more practical biomarker(s) which can also detect ARF
early, track drug treatment, and provide prognostic in-
formation. Ideally this biomarker would be easily mea-
sured in the serum or urinary proteome. Rapid develop-
ments in genomics and proteomics have provided new
tools for biomarker discovery [25] and hopefully will be
successfully applied to ARF. Dendrimer-enhanced MRI
may be useful as a tool to carefully phenotype patients
whose serum/urine will be subjected to proteomic anal-
ysis. Dendrimer-enhanced MRI may also provide im-
portant renal-specific severity of illness information that
can not be obtained from serum creatinine because of
the slow kinetics of creatinine in early ARF. Finally,
dendrimer-enhanced MRI may be useful in phase 1 and
early phase 2 studies as an intermediate (“surrogate”) end
point to better indicate therapeutic efficacy than standard
tests of renal function.
CONCLUSION
Dendrimer-enhanced MRI is an effective biomarker
for sepsis-induced ARF. It can detect renal injury early,
provide information about the cause, track the response
to therapy, and provide prognostic information. This
initial study of dendrimer-enhanced MRI in a mouse
model of sepsis-induced ARF supports this technique
being further validated and developed as an indepen-
dent biomarker and intermediate end point for human
studies.
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